Literature DB >> 20537122

The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders.

Vibeke Porsdal1, Catherine Beal, Ole Kristian Kleivenes, Egil W Martinsen, Eva Lindström, Harriet Nilsson, Pär Svanborg.   

Abstract

BACKGROUND: Solutions for Wellness (SfW) is an educational 3-month program concerning nutrition and exercise for persons with psychiatric disorders on psychotropic medication, who have weight problems. This observational study assessed the impact of SfW on subjective well-being, weight and waist circumference (WC).
METHODS: Data was collected at 49 psychiatric clinics. Where the SfW program was offered patients could enter the intervention group; where not, the control group. Subjective well-being was measured by the Subjective Well-being under Neuroleptics scale (SWN), at baseline, at the end of SfW participation, and at a follow-up 6 months after baseline. Demographic, disease and treatment data was also collected.
RESULTS: 314 patients enrolled in the SfW group, 59 in the control group. 54% of the patients had schizophrenia, 67% received atypical antipsychotics, 56% were female. They averaged 41 +/- 12.06 years and had a BMI of 31.4 +/- 6.35. There were significant differences at baseline between groups for weight, SWN total score and other factors. Stepwise logistic models controlling for baseline covariates yielded an adjusted non-significant association between SfW program participation and response in subjective well-being (SWN increase). However, statistically significant associations were found between program participation and weight-response (weight loss or gain < 1 kg) OR = 2; 95% CI [1.1; 3.7] and between program participation and WC-response (WC decrease or increase < 2 cm) OR = 5; 95% CI [2.4; 10.3]), at 3 months after baseline.
CONCLUSIONS: SfW program participation was associated with maintaining or decreasing weight and WC but not with improved subjective well-being as measured with the SWN scale.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537122      PMCID: PMC2898739          DOI: 10.1186/1471-244X-10-42

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  33 in total

1.  Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.

Authors:  L de Haan; M Weisfelt; P M A J Dingemans; D H Linszen; L Wouters
Journal:  Psychopharmacology (Berl)       Date:  2002-04-05       Impact factor: 4.530

2.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

3.  Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs.

Authors:  D Naber; S Moritz; M Lambert; F G Pajonk; R Holzbach; R Mass; B Andresen; F Rajonk
Journal:  Schizophr Res       Date:  2001-05-30       Impact factor: 4.939

Review 4.  Weight gain with antidepressants and lithium.

Authors:  E J Garland; R A Remick; A P Zis
Journal:  J Clin Psychopharmacol       Date:  1988-10       Impact factor: 3.153

5.  A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.

Authors:  D Naber
Journal:  Int Clin Psychopharmacol       Date:  1995-09       Impact factor: 1.659

Review 6.  Bodyweight change as an adverse effect of drug treatment. Mechanisms and management.

Authors:  H Pijl; A E Meinders
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

7.  Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program.

Authors:  Matthew Menza; Betty Vreeland; Shula Minsky; Michael Gara; Diane Rigassio Radler; Marie Sakowitz
Journal:  J Clin Psychiatry       Date:  2004-04       Impact factor: 4.384

8.  The effects of an educational intervention on antipsychotic-induced weight gain.

Authors:  Kimberly H Littrell; Nicole M Hilligoss; Carol D Kirshner; Richard G Petty; Craig G Johnson
Journal:  J Nurs Scholarsh       Date:  2003       Impact factor: 3.176

9.  A program for managing weight gain associated with atypical antipsychotics.

Authors:  Betty Vreeland; Shula Minsky; Matthew Menza; Diane Rigassio Radler; Beatrix Roemheld-Hamm; Robert Stern
Journal:  Psychiatr Serv       Date:  2003-08       Impact factor: 3.084

Review 10.  A review of the effect of atypical antipsychotics on weight.

Authors:  H Nasrallah
Journal:  Psychoneuroendocrinology       Date:  2003-01       Impact factor: 4.905

View more
  8 in total

Review 1.  Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.

Authors:  Emma E McGinty; Julia Baller; Susan T Azrin; Denise Juliano-Bult; Gail L Daumit
Journal:  Schizophr Bull       Date:  2015-07-28       Impact factor: 9.306

2.  The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: meta-analysis of intervention studies.

Authors:  Maria Isabel Fernández-San-Martín; Luis Miguel Martín-López; Roser Masa-Font; Noemí Olona-Tabueña; Yuani Roman; Jaume Martin-Royo; Silvia Oller-Canet; Susana González-Tejón; Luisa San-Emeterio; Albert Barroso-Garcia; Lidia Viñas-Cabrera; Gemma Flores-Mateo
Journal:  Community Ment Health J       Date:  2013-06-06

3.  A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia.

Authors:  Cecília Attux; Larissa C Martini; Hélio Elkis; Sérgio Tamai; Andréa Freirias; Maria das Graças Miquelutti Camargo; Mário Dinis Mateus; Jair de Jesus Mari; André F Reis; Rodrigo A Bressan
Journal:  BMC Psychiatry       Date:  2013-02-18       Impact factor: 3.630

Review 4.  Weight change in control group participants in behavioural weight loss interventions: a systematic review and meta-regression study.

Authors:  Lauren Waters; Alexis S George; Tien Chey; Adrian Bauman
Journal:  BMC Med Res Methodol       Date:  2012-08-08       Impact factor: 4.615

5.  The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis.

Authors:  Jojanneke Bruins; Frederike Jörg; Richard Bruggeman; Cees Slooff; Eva Corpeleijn; Marieke Pijnenborg
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

6.  Enhanced physical health screening for people with severe mental illness in Hong Kong: results from a one-year prospective case series study.

Authors:  Daniel Bressington; Jolene Mui; Sabina Hulbert; Eric Cheung; Stephen Bradford; Richard Gray
Journal:  BMC Psychiatry       Date:  2014-02-27       Impact factor: 3.630

7.  Beliefs about health, health risks and health expectations from the perspective of people with a psychotic disorder.

Authors:  Sally Hultsjö; Susanne Syren
Journal:  Open Nurs J       Date:  2013-08-20

Review 8.  Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.

Authors:  Petter Andreas Ringen; John A Engh; Astrid B Birkenaes; Ingrid Dieset; Ole A Andreassen
Journal:  Front Psychiatry       Date:  2014-09-26       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.